no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene
|
Williamson, E.D. |
|
1993 |
11 |
12 |
p. 1253-1258 6 p. |
article |
2 |
Calendar
|
|
|
1993 |
11 |
12 |
p. 1272- 1 p. |
article |
3 |
Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems
|
Holmgren, Jan |
|
1993 |
11 |
12 |
p. 1179-1184 6 p. |
article |
4 |
DNA segment encoding 30-kDa Borrelia burgdorferi antigenic polypeptide; for Lyme disease recombinant vaccine and diagnostic DNA probe and DNA primer production
|
|
|
1993 |
11 |
12 |
p. 1267- 1 p. |
article |
5 |
ELWW annual meeting
|
van Olrschot, J.T. |
|
1993 |
11 |
12 |
p. 1270-1271 2 p. |
article |
6 |
Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins
|
Charbit, A. |
|
1993 |
11 |
12 |
p. 1221-1228 8 p. |
article |
7 |
Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells
|
Fujii, Yoichi |
|
1993 |
11 |
12 |
p. 1240-1246 7 p. |
article |
8 |
GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3
|
Livingston, Philip O. |
|
1993 |
11 |
12 |
p. 1199-1204 6 p. |
article |
9 |
Haptoglobin polymorphism and the immune response after hepatitis B vaccination
|
Louagie, H. |
|
1993 |
11 |
12 |
p. 1188-1190 3 p. |
article |
10 |
Hepatitis B vaccination and booster in predialysis patients: A 4-year analysis
|
Dukes, Carol S. |
|
1993 |
11 |
12 |
p. 1229-1232 4 p. |
article |
11 |
Hepatitis C virus DNA sequence and protein sequence; recombinant vaccine and DNA probe for disease diagnosis
|
|
|
1993 |
11 |
12 |
p. 1268- 1 p. |
article |
12 |
Immune response related to the molecular structure of a peptide from the cholera toxin B subunit
|
Halimi, H. |
|
1993 |
11 |
12 |
p. 1233-1239 7 p. |
article |
13 |
Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors
|
Zheng, Bojian |
|
1993 |
11 |
12 |
p. 1191-1198 8 p. |
article |
14 |
Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit
|
Mbawuike, Innocent N. |
|
1993 |
11 |
12 |
p. 1205-1213 9 p. |
article |
15 |
Isolated DNA encoding antigen of mammal Pneumocystis carinii strain; for use in recombinant vaccine, antisense RNA, immunotoxin and diagnostic DNA probe or polymerase chain reaction DNA primer production
|
|
|
1993 |
11 |
12 |
p. 1267- 1 p. |
article |
16 |
Measles vaccine controversy
|
Silobrčić, V. |
|
1993 |
11 |
12 |
p. 1269-1270 2 p. |
article |
17 |
New Helicobacter pylori gene involved in functional urease expression; ureE, ureF, ureG, ureH and/or ureI gene cloning and expression in attenuated H. pylori or Escherichia coli for use as a recombinant vaccine; diagnostic DNA probe and DNA primer
|
|
|
1993 |
11 |
12 |
p. 1267- 1 p. |
article |
18 |
New recombinant vaccine for use against Actinobacillus pleuropneumoniae; transferrin binding protein, cytolysin or APP4 gene cloning and expression using a DNA cassette in a plasmid prAPP4 or plasmid p4-213-84 vector
|
|
|
1993 |
11 |
12 |
p. 1267- 1 p. |
article |
19 |
Plasmid comprising genes containing a base sequence encoding hepatitis non-A non-B virus antigen protein, virus promoters expressing the genes, and vaccinia virus genes non-essential to growth of vaccinia virus; non-A non-B hepatitis virus recombinant envelope protein antigen production in e.g. rabbit kidney RK-13 cell culture; potential recombinant vaccine
|
|
|
1993 |
11 |
12 |
p. 1267-1268 2 p. |
article |
20 |
Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice
|
Montaño-Hirose, Juan Antonio |
|
1993 |
11 |
12 |
p. 1259-1266 8 p. |
article |
21 |
Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus
|
Vanlandschoot, Peter |
|
1993 |
11 |
12 |
p. 1185-1187 3 p. |
article |
22 |
Role of EIPV in 1988 Israel polio outbreak
|
Slater, Paul E. |
|
1993 |
11 |
12 |
p. 1269- 1 p. |
article |
23 |
Serological correlates of susceptibility to pertussis
|
Lewis, David J.M. |
|
1993 |
11 |
12 |
p. 1269- 1 p. |
article |
24 |
Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
|
Danve, B. |
|
1993 |
11 |
12 |
p. 1214-1220 7 p. |
article |
25 |
Two-tag purification of recombinant proteins for the construction of solid matrix-antibody-antigen (SMAA) complexes as vaccines
|
Randall, R.E. |
|
1993 |
11 |
12 |
p. 1247-1252 6 p. |
article |
26 |
Type-C-like human retrovirus associated with multiple sclerosis, and monoclonal antibody and anti-idiotype antibody; and attenuated Epstein-Barr virus vaccine; DNA probe and RNA probe for application in diagnosis and therapy
|
|
|
1993 |
11 |
12 |
p. 1268- 1 p. |
article |
27 |
Vaccine comprising part of constant region of IgE; antiallergic recombinant vaccine production by IgE epsilon chain constant CH2–CH3 domain fusion protein expression in Escherichia coli; may be used in asthma, allergy and eczema therapy
|
|
|
1993 |
11 |
12 |
p. 1268- 1 p. |
article |